Lankenau Institute For Medical Research
- Assets
- $8.0m
- Revenue
- $9.1m
- Investments
- $0.0
- Employees
- 100
- Location
- Wynnewood, PA
- Founding
- 01/1982
- Data as of
- 06/2020
- EIN
- 23-2175659
Organization Overview
Lankenau Institute For Medical Research is located in Wynnewood, PA. The organization was established in 1982. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 06/2021, Lankenau Institute For Medical Research employed 100 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lankenau Institute For Medical Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2020, Lankenau Institute For Medical Research generated $9.1m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 0.4% each year. All expenses for the organization totaled $17.3m during the year ending 06/2020. While expenses have increased by 2.3% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
ADVANCE HUMAN HEALTH/WELL BEING, IMPROVE DETECTION/TREATMENT OF DISEASE, TRANSFER NEW TECHNOLOGY TO THE CLINIC & TRAIN THE NEXT GENERATION OF SCIENTISTS & PHYSICIANS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
BASIC RESEARCH LIMR BASIC RESEARCH FOCUSES ON THE ADVANCEMENT OF KNOWLEDGE FOR VARIOUS DISEASES AND CONDITIONS. IN CONJUNCTION WITH LIMR'S CORE RESEARCH PROGRAMS IN CANCER AND CARDIOVASCULAR DISEASE, LIMR INVESTIGATORS ALSO STUDY ARTHRITIS, DIABETES, LUPUS, INFECTIOUS DISEASE, NEUROLOGICAL DISORDERS, GASTROINTESTINAL DISEASE, REGENERATIVE MEDICINE AND POPULATION HEALTH, ALL WITH THE GOAL OF IMPROVING HEALTH AND WELL-BEING.
CLINICAL RESEARCH LIMR CLINICAL RESEARCH IS CONDUCTED PRIMARILY IN ONCOLOGY AND CARDIOLOGY BUT ALSO INCLUDES OTHER DISEASES AND DISORDERS. THIS MEANS PATIENTS AND PARTICIPANTS HAVE ACCESS TO STATE-OF-THE-ART CLINICAL TRIALS AND NEW TREATMENTS BEFORE THEY BECOME AVAILABLE TO THE GENERAL PUBLIC. THIS ALLOWS PATIENTS TO BE MORE ACTIVE IN THEIR HEALTH CARE.
NEW TECHNOLOGY / INNOVATIONS / OTHER LIMR HAS INITIATED A UNIQUE HYBRID MIX OF KNOWLEDGE-BASED ACADEMIC CULTURE WITH INVENTION-BASED ENTREPRENEURIAL CULTURE. IT IS CALLED AN ACAPRENEURIAL STRATEGY. TO DATE, MORE THAN 15 BIOMEDICAL START-UP COMPANIES HAVE INCUBATED IN LIMR SIDE-BY-SIDE WITH OUR RESEARCH LABORATORIES.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
George C Prendergast President & Ex-Officio Trustee | OfficerTrustee | 40 | $429,664 |
Charles Antzelevitch Executive Director | Officer | 40 | $280,518 |
Scott Dessain Assoc. Prof / Hat Dir | Officer | 40 | $228,714 |
Ellen Heber-Katz Professor | Officer | 40 | $193,484 |
Susan Gilmour Professor | Officer | 40 | $183,687 |
Tam Mai-Nguyen Director, Finance | Officer | 40 | $182,580 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
American Institute For Voice And Ea Research | 6/29/21 | $175,668 |
Rmcci Professional Svcs | 6/29/21 | $192,056 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Total Revenue from Contributions, Gifts, Grants & Similar | $4,439,873 |
| Investment income | -$14,707 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $42,754 |
| Net Rental Income | $237,022 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $9,109,367 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $2,235,290 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $5,059,683 |
| Pension plan accruals and contributions | $634,263 |
| Other employee benefits | $779,925 |
| Payroll taxes | $487,764 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $586,146 |
| Fees for services: Accounting | $91,611 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $1,342,676 |
| Advertising and promotion | $0 |
| Office expenses | $33,242 |
| Information technology | $7,325 |
| Royalties | $10,256 |
| Occupancy | $2,442,700 |
| Travel | $37,755 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $6,274 |
| Interest | $106,459 |
| Payments to affiliates | $624,734 |
| Depreciation, depletion, and amortization | $421,866 |
| Insurance | $3,471 |
| All other expenses | $0 |
| Total functional expenses | $17,253,320 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,320,633 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $966,251 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $205,638 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $101,545 |
| Intangible assets | $2,400 |
| Other assets | $3,511,360 |
| Total assets | $8,021,343 |
| Accounts payable and accrued expenses | $8,916,091 |
| Grants payable | $0 |
| Deferred revenue | $800,755 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $2,157,448 |
| Total liabilities | $11,874,294 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Total liabilities and net assets/fund balances | -$3,852,951 |
Grants Recieved
Over the last fiscal year, we have identified 6 grants that Lankenau Institute For Medical Research has recieved totaling $225,512.
| Awarding Organization | Amount |
|---|---|
Myasthenia Gravis Foundation Of America Inc Westborough, MA PURPOSE: Medical research | $110,000 |
The Gordon Charter Foundation Wayne, PA PURPOSE: FOR LIMR-COALA-T-OBS STUDY | $50,000 |
Louise A Havens Foundation For Diabetes Research And Treatment West Conshohocken, PA PURPOSE: MEDICAL RESEARCH PROJECT - UNDERSTANDING THE ROLE OF A UNIQUE BIOMARKER IN THE DEVELOPMENT OF DIABETES ASSOCIATED COMPLICATIONS | $25,000 |
Martha W Rogers Charitable Tr Uw 1084281m030 Pittsburgh, PA PURPOSE: GENERAL OPERATING | $14,844 |
Alliance Nctn Foundation Chicago, IL PURPOSE: INSTITUTIONAL SUPPORT FOR CANCER RESEARCH | $14,000 |
Alliance For Clinical Trials In Oncology Foundation Chicago, IL PURPOSE: CANCER RESEARCH | $11,668 |
Endowment Analysis
| Beg. Balance | $1,363,326 |
| Earnings | $315,341 |
| Ending Balance | $1,678,667 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Transcelerate Biopharma Inc West Conshohocken, PA | $50,373,384 | $31,090,660 |
The Health Collaborative Cincinnati, OH | $10,957,986 | $22,262,752 |
Lankenau Institute For Medical Research Wynnewood, PA | $8,021,343 | $9,109,367 |
Tri-Institutional Therapeutics Discovery Institute Inc New York, NY | $5,819,394 | $16,905,997 |
Zachary And Elizabeth M Fisher Center For Alzheimers Research Fdn New York, NY | $40,802,431 | $10,021,313 |
Coalition Of Cancer Cooperative Groups Philadelphia, PA | $21,235,863 | $14,701,631 |
American Thrombosis And Hemostasisnetwork Inc Rochester, NY | $10,168,996 | $13,364,540 |
University Of Maryland Family Medicine Associates Pa Baltimore, MD | $1,189,573 | $10,954,092 |
Football Research Inc New York, NY | $4,325,864 | $9,164,438 |
National Disease Research Interchange Philadelphia, PA | $6,059,781 | $7,072,153 |
Bronx Veterans Medical Research Foundation Inc Bronx, NY | $9,078,068 | $8,272,955 |
Citizens Committee For Children Of New York New York, NY | $3,634,711 | $3,821,090 |